A key part of a formal Strategic Business Plan for an investor-driven, Class II medical device startup is the Opportunities and Threats section. Traditionally, I like to identify not only the Opportunities, but the initiatives that we'll take in order to maximize our targeted opportunities. The converse is true; for every Threat or Risk, I like to identify Contingencies that can be at our fingertips to mitigate the risk at hand. Here's a quick overview on how both Generative

As a 37 year veteran of the medical device and life science market, I've been through some upheavals over the years. My first experience as a medical products manager goes back to the failed attempt to revamp the U.S. healthcare system in the early to mid-1990s. It unleashed a lot of price pressures on our industry that have never really receded. We're about to experience downward pressures once again. Going forward, small to mid-sized medtech companies should assume a st

Agentic AI is transforming the design and development of Class II medical devices by acting as a co-engineer that orchestrates complex tasks with minimal human intervention, accelerating product timelines while maintaining rigorous regulatory compliance. Its autonomy enables faster concept development, structured design controls, improved documentation, and real-time regulatory readiness.[1][2][3] Integrated Design Acceleration By automating and sequencing multi-step workflow

The intersection of strategic business planning, regulatory compliance, and artificial intelligence (AI) will in great part define the next decade of medical device innovation in the United States. As advances in machine learning, predictive analytics, and connected health technologies accelerate, medical device firms face a dual imperative: To harness AI-driven efficiency while maintaining rigorous adherence to the regulatory expectations of the Food and Drug Administration